Does ROSUVASTATIN\ROSUVASTATIN Cause Dyspnoea? 79 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 79 reports of Dyspnoea have been filed in association with ROSUVASTATIN\ROSUVASTATIN. This represents 14.2% of all adverse event reports for ROSUVASTATIN\ROSUVASTATIN.
79
Reports of Dyspnoea with ROSUVASTATIN\ROSUVASTATIN
14.2%
of all ROSUVASTATIN\ROSUVASTATIN reports
0
Deaths
30
Hospitalizations
How Dangerous Is Dyspnoea From ROSUVASTATIN\ROSUVASTATIN?
Of the 79 reports, 30 (38.0%) required hospitalization, and 6 (7.6%) were considered life-threatening.
Is Dyspnoea Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN\ROSUVASTATIN. However, 79 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN\ROSUVASTATIN Cause?
Asthma (77)
Pneumonia (52)
Acute kidney injury (50)
Wheezing (50)
Myalgia (48)
Drug hypersensitivity (46)
Fatigue (44)
Pain (44)
Rhabdomyolysis (43)
Arthralgia (41)
What Other Drugs Cause Dyspnoea?
ALBUTEROL (21,856)
TREPROSTINIL (16,348)
AMBRISENTAN (13,367)
PREDNISONE (12,830)
BUDESONIDE\FORMOTEROL (11,158)
TIOTROPIUM (10,863)
ADALIMUMAB (10,547)
DUPILUMAB (10,310)
FLUTICASONE\SALMETEROL (9,783)
MEPOLIZUMAB (9,192)
Which ROSUVASTATIN\ROSUVASTATIN Alternatives Have Lower Dyspnoea Risk?
ROSUVASTATIN\ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN\ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN\ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN\ROSUVASTATIN vs ROXITHROMYCIN
ROSUVASTATIN\ROSUVASTATIN vs ROZANOLIXIZUMAB